Reoviral Oncotropism Against c-Myc Overexpressing HS 68 Cells.
10.4167/jbv.2015.45.2.126
- Author:
Manbok KIM
1
Author Information
1. Department of Medical Science, Dankook University College of Medicine, Cheonan, Korea. manbok66@dankook.ac.kr
- Publication Type:Original Article
- Keywords:
Oncolytic virus;
Reovirus;
c-myc;
Oncogenes;
Reovirus oncolysis
- MeSH:
Caspase 3;
Genes, Tumor Suppressor;
Humans;
Oncogenes;
Oncolytic Viruses;
Telangiectasis;
Tropism
- From:Journal of Bacteriology and Virology
2015;45(2):126-131
- CountryRepublic of Korea
- Language:English
-
Abstract:
Naturally occurring reoviruses are live replication-proficient viruses specifically infecting human cancer cell while sparing normal counterpart. Since the discovery of reoviruses in 1950s, reoviruses have shown various degrees of safety and efficacy in pre-clinical or clinical application for human anti-cancer therapeutics. I have recently shown that cellular tumor suppressor genes, such as p53, ATM (Ataxia telangiectasia mutated), and RB (Retinoblastoma associated), are important in determining reoviral oncotropism. Thus, it is interesting to examine whether the aberrancy of c-Myc expression, whose normal function also plays an important role in the maintenance of genomic integrity, could affect reoviral oncolytic tropism. Hs68 cells are non-tumorigenic normal cells and resistant to reoviral cytopathic effects. Importantly, I found that c-Myc overexpression in human HS68 cells effectively induced reovirus cytophatic effects compared to mock expressed cells as shown by the typical reoviral cytophathology and an increased level of caspase-3 activity. Taken together, overexpression of c-Myc could play an important role in determining reoviral oncolytic tropism.
